IRIS Accounts Production v25.2.0.378 12566185 director 1.5.24 30.4.25 30.4.25 0 0 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh125661852024-04-30125661852025-04-30125661852024-05-012025-04-30125661852023-04-30125661852023-05-012024-04-30125661852024-04-3012566185ns15:EnglandWales2024-05-012025-04-3012566185ns14:PoundSterling2024-05-012025-04-3012566185ns10:Director12024-05-012025-04-3012566185ns10:PrivateLimitedCompanyLtd2024-05-012025-04-3012566185ns10:Micro-entities2024-05-012025-04-3012566185ns10:AuditExempt-NoAccountantsReport2024-05-012025-04-3012566185ns10:FullAccounts2024-05-012025-04-3012566185ns5:CurrentFinancialInstruments2025-04-3012566185ns5:CurrentFinancialInstruments2024-04-3012566185ns10:RegisteredOffice2024-05-012025-04-30
REGISTERED NUMBER: 12566185 (England and Wales)











Financial Statements for the Year Ended 30 April 2025

for

Capital Med Limited

Capital Med Limited (Registered number: 12566185)

Contents of the Financial Statements
for the Year Ended 30 April 2025










Page

Balance Sheet 1


Capital Med Limited (Registered number: 12566185)

Balance Sheet
30 April 2025

2025 2024
£    £    £    £   
FIXED ASSETS - 682

CURRENT ASSETS 32 16,197

CREDITORS
Amounts falling due within one year 106 (14,692 )
NET CURRENT ASSETS 138 1,505
TOTAL ASSETS LESS CURRENT
LIABILITIES

138

2,187

CAPITAL AND RESERVES 138 2,187

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Capital Med Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12566185

Registered office: 42 Saxholm Dale
Southampton
Hampshire
SO16 7HA

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was NIL (2024 - NIL).



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 18 August 2025 and were signed by:





Dr O Iqbal - Director